Simple and sensitive LC-UV method for simultaneous analysis of hydrochlorothiazide and candesartan cilexetil in pharmaceutical formulations

• Autorzy: Qutab S. S. , Razzaq S. N. , Ashfaq M. , Shuja Z. A. , Khan I. U.
• Języki publikacji: EN

Abstrakty

EN

A simple, sensitive, and inexpensive high-performance liquid-chromatographic method has been developed for simultaneous determination of hydrochlorothiazide and candesartan cilexetil in pharmaceutical formulations. Chromatographic separation was achieved on a Phenyl-2 column with a 25:75:0.2 mixture of 0.02 M potassium dihydrogen phosphate, methanol, and triethylamine, final pH 6.0 š 0.1, as mobile phase. Detection was at 271 nm. Response was a linear function of concentration in the range 5–45 µg mL-1 for hydrochlorothiazide and 12–56 µg mL-1 for candesartan cilexetil; the correlation coefficients were 0.9993 and 0.9991, respectively. Total elution time for the two components was less than 5 min.

• Wydawca: University of Silesia in Katowice ; Akademiai Kiado
• Czasopismo: Acta Chromatographica
• Rocznik: 2007
• Tom: No. 19
• Strony: 119--129
• Opis fizyczny: Bibliogr. 20 poz., rys., tab.

Twórcy

autor

Qutab S. S.

autor

Razzaq S. N.

autor

Ashfaq M.

autor

Shuja Z. A.

autor

Khan I. U.

• Schazoo Laboratories (Pvt) Ltd, 45 G.T. Road, Lahore-54000, Pakistan

Bibliografia

• [1] A. Vonaparti, M. Kazanis, and I. Panderi, J. Mass. Spectrom., 41, 593 (2006)
• [2] N.V. Ramakrishna, K.N. Vishwottam, S. Manoj, M. Koteshwara, S. Wishu, and D.P. Varma, Biomed. Chromatogr., 19, 751 (2005)
• [3] O. Abdel Razak, J. Pharm. Biomed. Anal., 34, 433 (2004)
• [4] M.C. Ferraro, P.M. Castellano, and T.S. Kaufman, J. Pharm. Biomed. Anal., 30, 1121 (2002)
• [5] E. Dinc and D. Baleanu, J. Pharm. Biomed. Anal., 30, 715 (2002)
• [6] A. Jończyk and Z. Nowakowska, Acta Pol. Pharm., 58, 339 (2001)
• [7] S.A. Shah, I.S. Rathod, B.N. Suhagia, S.S. Savale, and J.B. Patel, JAOAC Int., 84, 1715 (2001)
• [8] E. Satana, S. Altinay, N.G. Goger, S.A. Ozkan, and Z. Senturk, J. Pharm. Biomed. Anal., 25, 1009 (2001)
• [9] N. Erk, J. Pharm. Biomed. Anal., 24, 603 (2001)
• [10] M.G. Quaglia, E. Donati, G. Carlucci, P. Mazzeo, and S. Fanali, J. Pharm. Biomed. Anal., 29, 981 (2002)
• [11] D.L. Hertzog, J.F. McCafferty, X. Fang, R.J. Tyrrell, and R.A. Reed, J. Pharm. Biomed. Anal., 30, 747 (2002)
• [12] F. Belal, I.A. Al-Zaagi, E.A. Gadkariem, and M.A. Abounassif, J. Pharm. Biomed. Anal., 24, 335 (2001)
• [13] G. Carlucci, G. Palumbo, P. Mazzeo, and M.G. Quaglia, J. Pharm. Biomed. Anal., 23, 185 (2000)
• [14] J. Kirschbaum and S. Perlman, J. Pharm. Sci., 73, 686 (1984)
• [15] G.N. Menon and L.B. White, J. Pharm. Sci., 70, 1083 (1981)
• [16] L. Gonzalez, J.A. Lopez, R.M. Alonso, and R.M. Jimenez, J. Chromatogr. A, 949, 49 (2002)
• [17] H. Stenhoff, P.O. Lagerstrom, and C. Andersen, J. Chromatogr. B, 731, 411 (1999)
• [18] E. Cagigal, L. Gonzalez, R.M. Alonso, and R.M. Jimenez, J. Pharm. Biomed. Anal., 26, 477 (2001)
• [19] N. Erk, J. Liq. Chromatogr. Related Technol., 26, 2581 (2003)
• [20] N. Erk, Pharmazie, 58, 796, (2003)